Ra Medical Systems Launches Pharos, Optimized Dermatology Excimer Laser. Credit: Business Wire.

Ra Medical Systems has launched Pharos, Optimized, a dermatology excimer laser for the treatment of patients with psoriasis, vitiligo, and atopic dermatitis.

The new device features an ergonomic handpiece to offer comfort for the operator and better visibility of the treatment site. Ra Medical said that Pharos is intended to improve both physician and patient experience.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The device also comes with adjustable aiming and laser beams in order to enable targeted treatments without affecting healthy tissue. Pharos’ small footprint makes it suitable for any type of treatment room.

Ra Medical Systems CEO Dean Irwin said: “The optimised Pharos is a next-generation laser that delivers what dermatologists have been asking for: faster treatments for psoriasis, vitiligo, and atopic dermatitis and an upgraded user and patient experience.”

According to the company, psoriasis, vitiligo, and atopic dermatitis impact a total of more than 25 million people living in the US. Pharos, Optimized is expected to offer a new treatment option for these conditions.

The new device has been initially displayed at the 2019 American Academy of Dermatology Summer Meeting held from 25 July to 28 July in New York, US.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Ra Medical develops excimer laser systems targeting vascular and dermatologic diseases. The company introduced Pharos in 2004 to treat dermatological conditions, including psoriasis, vitiligo, and atopic dermatitis.

The company launched DABRA later in 2017, providing an endovascular treatment for blockages caused by lower extremity vascular disease.

Both devices are powered by the company’s excimer laser technology platform, which generates 308nm light that is believed to produce a targeted immunosuppressive effect.

The company operates a 32,000ft² manufacturing facility in Carlsbad, California, US for making DABRA and Pharos excimer lasers and catheters.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.

Discover the Impact